{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:19:24Z","timestamp":1789924764507,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jneuroim.2012.04.002","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T11:14:52Z","timestamp":1337771692000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis"],"prefix":"10.1016","volume":"249","author":[{"given":"Windy","family":"Allman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsher S.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Tuzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premkumar","family":"Christadoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.04.002_bb0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1749-6632.1993.tb22938.x","article-title":"Clinical improvement of myasthenia gravis by treatment with a chimeric anti-CD4 monoclonal antibody","volume":"681","author":"Ahlberg","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2005.09.024","article-title":"Infections and autoimmune diseases","volume":"25","author":"Bach","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1084\/jem.151.1.204","article-title":"Experimental myasthenia gravis. A murine system","volume":"151","author":"Berman","year":"1980","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0020","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1189\/jlb.70.6.849","article-title":"Modes of action of Freund's adjuvants in experimental models of autoimmune diseases","volume":"70","author":"Billiau","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrd2085","article-title":"B cells move to centre stage: novel opportunities for autoimmune disease treatment","volume":"5","author":"Browning","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0030","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity","volume":"5","author":"Carroll","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0035","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.4049\/jimmunol.136.7.2437","article-title":"Immunotherapy for myasthenia gravis: a murine model","volume":"136","author":"Christadoss","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-8749(83)90205-8","article-title":"Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies","volume":"81","author":"Christadoss","year":"1983","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clim.1999.4807","article-title":"Animal models of myasthenia gravis","volume":"94","author":"Christadoss","year":"2000","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0050","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/clin.1998.4535","article-title":"The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis","volume":"87","author":"Dedhia","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0198-8859(99)00117-2","article-title":"Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of Myasthenia gravis?","volume":"61","author":"Deitiker","year":"2000","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0070","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/096120339400300614","article-title":"Long-lasting effects of bacterial lipopolysaccharide promote progression of lupus nephritis in NZB\/W mice","volume":"3","author":"Granholm","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0080","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.4049\/jimmunol.166.11.6893","article-title":"Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4","volume":"166","author":"Im","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.it.2005.03.009","article-title":"Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection","volume":"26","author":"Kamradt","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0090","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.152.6.3152","article-title":"Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis","volume":"152","author":"Kaul","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0095","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1023\/A:1023361912950","article-title":"Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA\/CpG oligonucleotides","volume":"23","author":"Lenert","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O","article-title":"Acetylcholine receptors and myasthenia","volume":"23","author":"Lindstrom","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0110","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.4049\/jimmunol.179.5.2695","article-title":"Cutting edge: complement (C3d)-linked antigens break B cell anergy","volume":"179","author":"Lyubchenko","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2006.07.004","article-title":"CD4+ T and B cells cooperate in the immunoregulation of experimental autoimmune myasthenia gravis","volume":"179","author":"Milani","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1600-065X.2003.00055.x","article-title":"The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease","volume":"194","author":"O'Connor","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2004.04.019","article-title":"ICOS is essential for the development of experimental autoimmune myasthenia gravis","volume":"153","author":"Scott","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0130","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3587::AID-IMMU3587>3.0.CO;2-Y","article-title":"Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis","volume":"28","author":"Shi","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0135","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.4049\/jimmunol.172.9.5743","article-title":"Circulating immune complexes augment severity of antibody-mediated myasthenia gravis in hypogammaglobulinemic RIIIS\/J mice","volume":"172","author":"Tuzun","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0140","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0952-7915(93)90105-2","article-title":"Myasthenia gravis","volume":"5","author":"Willcox","year":"1993","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0145","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.4049\/jimmunol.159.6.3016","article-title":"Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis","volume":"159","author":"Wu","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0150","article-title":"Experimental autoimmune myasthenia gravis in the mouse","author":"Wu","year":"2001","journal-title":"Curr. Protoc. Immunol"},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2567.2000.00015.x","article-title":"Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice","volume":"99","author":"Yoshino","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2012.04.002_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.184.2.349","article-title":"Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis","volume":"184","author":"Zhang","year":"1996","journal-title":"J. Exp. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:19:00Z","timestamp":1759047540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812001026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0165572812001026"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.04.002","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}